Navigate Pneumococcal Vaccines for Adults
Ongoing changes with pneumococcal vaccine recommendations for adults can make your head spin.
Last year, CDC recommended Prevnar 20 (PCV20) or Vaxneuvance (PCV15) over Pneumovax 23 (PPSV23) alone for eligible adults...those 65 and up or 19 to 64 with risk factors (cancer, diabetes, smoking, etc).
Now CDC’s updated immunization schedule clarifies the role of PCV20 to finish an incomplete series...or for adults who’ve had Prevnar 13 (PCV13) plus PPSV23.
Get concise advice on drug therapy, plus unlimited access to CE
Hospital Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote